1,8-Naphthyridine-3-carboxylic acid,1-ethyl-1,4-dihydro-7-methyl-4-oxo-, sodium salt
CAS: 3374-05-8
Rif. IN-DA00I6N3
| 1g | Fuori produzione | ||
| 5g | Fuori produzione | ||
| 25g | Fuori produzione | ||
| 100mg | Fuori produzione |
Informazioni sul prodotto
Nome:
1,8-Naphthyridine-3-carboxylic acid,1-ethyl-1,4-dihydro-7-methyl-4-oxo-, sodium salt
Sinonimi:
- [u'Acid, Nalidixic', u'Anhydrous, Nalidixate Sodium', u'Nalidixate Sodium', u'Nalidixate Sodium Anhydrous', u'Nalidixic Acid', u'Nalidixin', u'Nevigramon', u'Sodium Anhydrous, Nalidixate', u'Sodium Nalidixic Acid, Anhydrous', u'Sodium Nalidixic Acid, Monohydrate', u'Sodium, Nalidixate', u'Nalidixic acid sodium salt', u'Baktogram', u'Nalidixic acid sodium', u'3374-05-8', u'Sodium nalidixate', u'Chemiurin', u'Dixilina', u'NALIDIXATE SODIUM', u'UNII-Y7NU182221', u'Nalidixate sodium anhydrous [USAN]', u'EINECS 222-159-7', u'MFCD00064376', u'Y7NU182221', u'Win 18320', u'1-Ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid sodium salt', u'Nalidixate sodium anhydrous', u'Sodium 1-ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate', u'CPD000326712', u'SMR000326712', u'AC1MYZ5W', u'Lopac-N-4382', u'MLS001056754', u'MLS002548848', u'Nalidixate Sodium (anhydrous)', u'SCHEMBL9743577', u'CHEMBL1255939', u'CTK8B3279', u'Sodium Nalidixic Acid, Anhydrous', u'BIN4302', u'ZX-AFC000602', u'HMS3262H15', u'HMS3714G09', u'Tox21_500837', u'ANW-42193', u'GA0875', u'AKOS024307522', u'AKOS026749975', u'API0003487', u'CCG-220674', u'CCG-222141', u'LP00837', u'WIN-183203', u'NCGC00016177-01', u'NCGC00016177-02', u'NCGC00016177-03', u'NCGC00094168-01', u'NCGC00261522-01', u'BP-12504', u'LS-95957', u'SAM002264626', u'SAM002699905', u'EU-0100837', u'FT-0634810', u'K-0042', u'N 4382', u'C-25525', u'J-009440', u'J-019311', u'sodium 1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate', u'potassium 1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate', u'sodium 1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate', u'1-Ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid sodium', u'1-OO>>u-1,4- paragraph signthornCa-7-(1/4)x>>u-4-No u-1,8-YAa currency-3-oEEa AAENI', u'nalidixic acid', u'C12H11N2O3.Na', u'Nalidixic acid sodium salt hydrate', u'CID27477', u'CID3864541', u'NALIDIXIC ACID, SODIUM SALT HYDRATE', u'Nalidixic acid sodium salt, 98% - 1G 1g', u'1-Ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid', u'15769-77-4']
- 1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-1,4-dihydro-7-methyl-4-oxo-, sodium salt
- 1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-1,4-dihydro-7-methyl-4-oxo-, sodium salt (1:1)
- Nalidixate sodium
- Nalidixic Acid Sodium
- Nalidixic Acid Sodium Gamma-Irradiated*Molecular
- Sodium 1-Ethyl-7-Methyl-4-Oxo-1,4-Dihydro-1,8-Naphthyridine-3-Carboxylate
- Sodium 1-ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate
- Sodium nalidixate
- Win 18320-3
- Vedi altri sinonimi
Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Indagoo
Conservazione lunga:
Note:
Proprietà chimiche
Peso molecolare:
254.2171
Formula:
C12H11N2NaO3
Purezza:
98%
Colore/Forma:
Solid
InChI:
InChI=1S/C12H12N2O3.Na/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14;/h4-6H,3H2,1-2H3,(H,16,17);/q;+1/p-1
InChI key:
ROKRAUFZFDQWLE-UHFFFAOYSA-M
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:
